Olr192 inhibitors represent a unique and emerging class of chemical compounds that have drawn interest primarily due to their interaction with a specific olfactory receptor, Olr192. Olfactory receptors (ORs) are a broad family of G-protein-coupled receptors (GPCRs) primarily known for their role in the detection of odorants. However, recent studies have expanded their relevance beyond the olfactory system, identifying their expression in various non-olfactory tissues. Olr192 is one such receptor that has been found to exhibit specific binding affinities with certain ligands. Inhibitors of Olr192 are characterized by their ability to bind selectively to this receptor, blocking its interaction with its native ligands, which may include small volatile organic molecules or specific endogenous signaling molecules. These inhibitors often possess a molecular architecture that facilitates high affinity binding to the receptor's active site, effectively modulating its functional state.
The structural diversity of Olr192 inhibitors is noteworthy, as it reflects the complexity of the receptor's binding pocket, which can accommodate a range of molecular scaffolds. Researchers have identified various classes of these inhibitors, including small molecules, peptides, and even engineered proteins, each with distinct physicochemical properties. The design and synthesis of Olr192 inhibitors often involve a deep understanding of the receptor's three-dimensional structure, allowing for the development of molecules that can interact with specific amino acid residues crucial for receptor activation. Additionally, the study of Olr192 inhibitors provides insights into the broader GPCR signaling pathways, as the inhibition of this receptor can reveal the functional roles of Olr192 in various cellular contexts. Through advanced computational modeling and structure-activity relationship (SAR) studies, scientists continue to refine these inhibitors, enhancing their specificity and potency, thereby contributing to the broader understanding of olfactory receptor biology and GPCR-mediated signal transduction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $79.00 $416.00 | 1 | |
Beta-blocker, may affect cardiac signaling, potentially impacting Olr192. | ||||||
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $49.00 $91.00 | 21 | |
ACE inhibitor, could modulate blood pressure regulation, impacting Olr192. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Cholesterol absorption inhibitor, may affect lipid metabolism, impacting Olr192. | ||||||
Finasteride | 98319-26-7 | sc-203954 | 50 mg | $105.00 | 3 | |
5-alpha-reductase inhibitor, can affect hormone levels, potentially impacting Olr192. | ||||||
Gabapentin | 60142-96-3 | sc-201481 sc-201481A sc-201481B | 20 mg 100 mg 1 g | $53.00 $94.00 $135.00 | 7 | |
GABA analog, might modulate neuronal activity, impacting Olr192. | ||||||
Liraglutide | 204656-20-2 | sc-507404 | 1 mg | $220.00 | ||
GLP-1 receptor agonist, may influence glucose metabolism, impacting Olr192. | ||||||
Memantine hydrochloride | 41100-52-1 | sc-203628 | 50 mg | $69.00 | 4 | |
NMDA receptor antagonist, can modulate neuronal signaling, potentially impacting Olr192. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Calcium channel blocker, might affect vascular smooth muscle function, impacting Olr192. | ||||||
Olanzapine | 132539-06-1 | sc-212469 | 100 mg | $133.00 | 6 | |
Atypical antipsychotic, could modulate neurotransmitter receptors, impacting Olr192. | ||||||
Pravastatin, Sodium Salt | 81131-70-6 | sc-203218 sc-203218A sc-203218B | 25 mg 100 mg 1 g | $69.00 $162.00 $787.00 | 2 | |
HMG-CoA reductase inhibitor, may affect cholesterol synthesis, impacting Olr192. | ||||||